- Home
- TSBK vs AQST Comparison
TSBK vs AQST Comparison
Compare TSBK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBK
- AQST
- Stock Information
- Founded
- TSBK 1915
- AQST 2004
- Country
- TSBK United States
- AQST United States
- Employees
- TSBK N/A
- AQST N/A
- Industry
- TSBK Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- TSBK Finance
- AQST Health Care
- Exchange
- TSBK Nasdaq
- AQST Nasdaq
- Market Cap
- TSBK 244.2M
- AQST 274.4M
- IPO Year
- TSBK 1998
- AQST 2018
- Fundamental
- Price
- TSBK $30.15
- AQST $2.94
- Analyst Decision
- TSBK
- AQST Strong Buy
- Analyst Count
- TSBK 0
- AQST 7
- Target Price
- TSBK N/A
- AQST $10.57
- AVG Volume (30 Days)
- TSBK 13.9K
- AQST 1.4M
- Earning Date
- TSBK 04-22-2025
- AQST 03-05-2025
- Dividend Yield
- TSBK 3.27%
- AQST N/A
- EPS Growth
- TSBK N/A
- AQST N/A
- EPS
- TSBK 3.10
- AQST N/A
- Revenue
- TSBK $75,328,000.00
- AQST $57,561,000.00
- Revenue This Year
- TSBK N/A
- AQST N/A
- Revenue Next Year
- TSBK N/A
- AQST $39.51
- P/E Ratio
- TSBK $9.90
- AQST N/A
- Revenue Growth
- TSBK N/A
- AQST 13.79
- 52 Week Low
- TSBK $23.93
- AQST $2.24
- 52 Week High
- TSBK $33.98
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- TSBK 48.48
- AQST 47.23
- Support Level
- TSBK $29.49
- AQST $3.05
- Resistance Level
- TSBK $30.99
- AQST $3.24
- Average True Range (ATR)
- TSBK 0.62
- AQST 0.20
- MACD
- TSBK 0.06
- AQST 0.02
- Stochastic Oscillator
- TSBK 52.81
- AQST 36.18
About TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.